Briota Technologies

Briota Technologies is an award-winning MedTech company established in February 2018 with headquarters in India. The company is on a mission to help 10M patients improve lung health by 2030. Briota is committed to innovating tech solutions for remote care, diagnostics, and management for chronic respiratory conditions, particularly for patients with moderate to severe asthma and COPD. Their AI-first approach simplifies the diagnostics and lifecycle management of Chronic Respiratory Ailments in a post Covid-19 world. Notably, Briota's work in Prioritizing Care for Covid-19 patients using the power of AI and ML has helped reduce the Case Fatality Rate in patients with comorbidities. The Government of India – Department of Science, BIRAC, and Technology Development Board has funded the R&D work of Briota. Additionally, Briota's Covid-19 Home Management service has benefitted over 15000 patients in Mumbai and is currently being implemented for over 40,000 workmen colony members in Tier II and Tier III cities like Renukoot, Hirakud, Utkal, etc. Overall, Briota Technologies is at the forefront of revolutionizing healthcare through innovative tech solutions and has demonstrated substantial success in addressing respiratory health challenges, positioning itself as a promising investment opportunity for venture capitalists.